August 2008
Generics manufacturers have prospered in Central and Eastern European markets of late, but the regulatory landscape is changing. Companies must take action if they are to surmount the competition.
Abstract
May 2008
A combination of reforms is needed to ease the burden on Japan’s health care system
Abstract
February 2008
China’s pharmaceutical market is growing by upward of 20 percent a year, but global drug companies still must capture its full potential.
Abstract
December 2007
Makers of generic and branded drugs alike stand to gain by developing the country's fledgling market.
Abstract
September 2007
For pharmaceutical and medical-product companies, adopting world-class manufacturing processes can create a competitive advantage by reducing regulatory risk and production costs.
Abstract
July 2007
The first wave of IT improvements solved some problems, but opportunities remain. Now it’s time for a more comprehensive approach.
Abstract
June 2007
During the next five years, rapid innovation may restructure the value chain of health care payments and change the sector’s balance of power.
Abstract
March 2007
To encourage the private sector, governments must learn how to regulate the health care industry appropriately.
Abstract
February 2007
A health care system's fundamental problems can be addressed if the decision makers recognize the interlocking nature of its elements.
Abstract
March 2007
More and more, payers are dealing with individual consumers, not companies. They will have to change their products, their mind-sets, and their competencies.
Abstract
February 2007
Battered by competition and regulation, hospitals need fast, dramatic treatment: leadership that thinks strategically, builds quality, and aligns doctors with the goals of hospitals.
Abstract